Chemical formula: C₉₇H₁₄₄FN₃₃O₁₉S₂ Molecular mass: 2,159.078 g/mol PubChem compound: 91865076
Motixafortide is indicated for:
Population group: only adults (18 years old or older)
Motixafortide is indicated in combination with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
